title: Reply: 'Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.
authors.affiliation: Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 Leiden, ZA, The Netherlands.
authors.forename: P M
authors.initials: PM
authors.lastname: Willemse
authors.forename: J
authors.initials: J
authors.lastname: Burggraaf
authors.forename: N A T
authors.initials: NA
authors.lastname: Hamdy
authors.forename: S
authors.initials: S
authors.lastname: Osanto
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology*; D006801:Humans; D007006:Hypogonadism / Q000453:epidemiology*; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology*; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000453:epidemiology*; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000453:epidemiology*
references.citation: Bone. 1996 Feb;18(2):171-7
references.pmid: 8833211
references.citation: Int J Obes. 1991 Nov;15(11):791-5
references.pmid: 1778664
references.citation: Diabetes Care. 2011 Apr;34(4):828-37
references.pmid: 21386088
references.citation: Obes Res. 1993 Jul;1(4):245-51
references.pmid: 16350577
references.citation: Eur J Endocrinol. 2006 Jun;154(6):899-906
references.pmid: 16728551
references.citation: Aging Male. 2003 Mar;6(1):1-7
references.pmid: 12809074
references.citation: Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113
references.pmid: 17726407
references.citation: Br J Cancer. 2013 Jul 9;109(1):60-7
references.pmid: 23660945
references.citation: J Androl. 2009 Nov-Dec;30(6):726-33
references.pmid: 19578132
references.citation: Br J Cancer. 2013 Oct 29;109(9):2502-3
references.pmid: 24045657